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LETTER TO THE EDITOR
Reply: Evaluation of the quantitative fetal fibronectin test and PAMG-1 test
for the prediction of spontaneous preterm birth in patients with signs and
symptoms suggestive of preterm labor
Sir,
Ravi et al. boldly state that quantitative fetal fibronectin (fFN)
with a cutoff threshold of 200ng/mL has no clinical advantage,
despite having a higher positive predictive value (PPV). The
authors assume that a threshold of 200ng/mL would be used
to “rule out” preterm birth and fail to appreciate that the
strengths of quantitative fFN use in clinical practice do not rely
on arbitrary cutoffs.
Through using the entire range of quantitative fFN,
predictive abilities and in turn clinical utility is not limited
to a fixed threshold. High levels of quantitative fFN can
be used to improve PPV, while low levels can be used to
rule out imminent delivery. In clinical practice, ruling out
imminent delivery is far more important; clinicians only
withhold treatment for women at very low risk, but will
treat most women at moderate risk or higher [1].
The absence of a power calculation, a small sample of
72 patient and an event rate of only three women who
delivered within 7 d of presenting limits the statistical
certainty of their findings. Although the authors acknow-
ledge these shortcomings within the discussion, they
state that the “PAMG-1 test is a better predictor of spon-
taneous delivery” and claim that the “PAMG-1 test was
statistically superior”. Both statements are misleading.
The authors found that both PAMG-1 and fFN (at 10 and
50ng/mL) have the same sensitivity (67%). Both have poor
sensitivity – one third of women who go on to have a
preterm birth would be falsely reassured. However, the wide
confidence interval (67%, CI 9.43–99.6) make these statistics
(and all of their statistics) almost meaningless; this implies in
women with actual preterm birth, over 90% could have a
negative test, or the test is near perfect. Bigger studies
are needed.
By combining quantitative fFN, cervical length and
medical history, we have been able to improve prediction
statistics to clinically useful levels in appropriately
powered studies [2,3]. These are currently being trialed in
clinical practice.
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